RecruitingNCT07139899

Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma

Downstream Effects of Airway Mucus Plugs on 129Xenon MRI Following Biologic Therapy


Sponsor

Bastiaan Driehuys

Enrollment

5 participants

Start Date

Nov 17, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with severe asthma. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is using a specialized MRI scan with inhaled xenon gas (129Xe MRI) to look at how mucus plugs in the airways of people with severe asthma affect lung function, and whether this improves after starting certain biologic asthma medications. **You may be eligible if...** - You are 18 to 65 years old - You have had a doctor's diagnosis of asthma for more than 1 year - Your blood eosinophil count is elevated (above 300 cells/μL), indicating an inflammatory type of asthma - You are about to start a biologic asthma medication (dupilumab, tezepelumab, or benralizumab) as part of your regular care - Your smoking history is minimal (fewer than 10 pack-years) and you have not smoked in the past 3 months **You may NOT be eligible if...** - You have had a respiratory infection in the past 4 weeks - Your BMI is above 30 - You are not starting one of the specified biologic asthma medications - You have had a recent significant medical procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTHyperpolarized Xenon 129

Pulmonary magnetic resonance imaging using hyperpolarized xenon-129 gas as an inhaled contrast agent


Locations(1)

Duke University Medical Center

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07139899


Related Trials